KiraGen is honored to announce our latest achievement – taking home the top prize at the Harvard Undergraduate Capital Partners Innovation Fund x Consulting, Business, and the Environment Ventures Competition. This accolade is a significant affirmation of our dedication to revolutionizing cancer treatment through our innovative CAR-T cell therapies. Receiving this recognition is a milestone that not only validates our scientific and entrepreneurial efforts but also propels us forward with additional resources and support. The award, a testament to our team's hard work and the potential of our technology, provides us with invaluable opportunities, including a prioritized application to become part of the Z Fellows Program. This would enable us to immerse ourselves in intensive development, guided by mentorship from leading experts, and to collaborate with a cohort of exceptional technical builders. We're deeply thankful for this honor and remain committed to our mission to deliver transformative solutions in the fight against cancer.